← Back to Patent Explorer
US3013941A Expired / Lapsed US ⏱️ 0.0 years remaining

Mastitis composition

Assignee: Elgin Pharmaceutical Co
•
Filing: 1958-05-09
•
Granted: 1961-12-19
•
Expires: 1978-05-09
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

No abstract record available.

Inventors

  • 👤 Gunderson Harvey

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-31 01:40
CPC Classifications
A; A61; A61K; A61K9/00; A61K9/0012; A61K9/0041

Claims Analysis

Total Claims: 1
Claim 1
Independent Claim 60 words
A COMPOSITION COMPRISING A THERAPEUTIC DOSE OF AT LEAST ONE SUBSTANCE FROM THE CLASS DEFINED BY CHEMOTHERAPEUTIC AGENTS AND METABOLIC ANTAGONISTS EFFECTIVE AGAINST PATHOGENS CAUSING MASTITIS, APPROXIMATELY 3.5 GRAMS OF TOTAL MILK SOLIDS, REGARDLESS OF THEIR SOURCE, DERIVED BY HEATING MILK, AND SUBSTANTIALLY FREE FROM TISSUE ALLERGENIC, INFLAMMATORY AND IRRITATING FACTORS, AND ABOUT TEN MILLITERS OF AN INERT FLOWABLE MATERIAL.

References Cited (Backward Citations)

US2110208A Cited
US2498374A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1964-12-18 1965-06-19 1965-12-19 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1968-12-18 1969-06-19 1969-12-19 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1972-12-18 1973-06-19 1973-12-19 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag